147 related articles for article (PubMed ID: 32692213)
1. Serum level of soluble CD14 subtype predicts long-term prognosis in sepsis patients with cardiac dysfunction.
Liu J; Dai M; Yang H; Song L; Chen K; Wang Y; Hua M
Ann Palliat Med; 2020 Jul; 9(4):2054-2061. PubMed ID: 32692213
[TBL] [Abstract][Full Text] [Related]
2. [Value of N-terminal pro-brain natriuretic peptide in evaluating early septic cardiac dysfunction in neonates].
Yang C; Liu F; Han M; Li B; Shen Q; Xu P; Yang Q
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jun; 32(6):711-715. PubMed ID: 32684218
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis.
Yaegashi Y; Shirakawa K; Sato N; Suzuki Y; Kojika M; Imai S; Takahashi G; Miyata M; Furusako S; Endo S
J Infect Chemother; 2005 Oct; 11(5):234-8. PubMed ID: 16258819
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of left ventricular systolic function and cardiac biomarkers in pediatric severe sepsis.
Li J; Ning B; Wang Y; Li B; Qian J; Ren H; Zhang J; Hu X
Medicine (Baltimore); 2019 Mar; 98(13):e15070. PubMed ID: 30921240
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD14 Subtype in Peripheral Blood is a Biomarker for Early Diagnosis of Sepsis.
Zhou W; Rao H; Ding Q; Lou X; Shen J; Ye B; Xiang C
Lab Med; 2020 Nov; 51(6):614-619. PubMed ID: 32382753
[TBL] [Abstract][Full Text] [Related]
6. Combined use of high-sensitivity ST2 and NT-proBNP for predicting major adverse cardiovascular events in coronary heart failure.
Bai J; Han L; Liu H
Ann Palliat Med; 2020 Jul; 9(4):1976-1989. PubMed ID: 32762223
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS.
Mussap M; Puxeddu E; Puddu M; Ottonello G; Coghe F; Comite P; Cibecchini F; Fanos V
Clin Chim Acta; 2015 Dec; 451(Pt A):65-70. PubMed ID: 26232159
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic value of heart-type fatty acid-binding protein combined with echocardiography in sepsis with cardiac insufficiency].
Ding R; Cheng Q; Tian P; Guli B; Xu C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):478-482. PubMed ID: 32527357
[TBL] [Abstract][Full Text] [Related]
9. [Predictive value of early phrase echocardiography and cardiac biological markers in patients with severe sepsis: a five-year single-center retrospective study].
Zang X; Chen W; Sheng B; Zhao L; Gu X; Zhen J; Liu P
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Apr; 30(4):332-336. PubMed ID: 29663994
[TBL] [Abstract][Full Text] [Related]
10. High Serum sTREM-1 Correlates With Myocardial Dysfunction and Predicts Prognosis in Septic Patients.
Li Z; Zhang E; Hu Y; Liu Y; Chen B
Am J Med Sci; 2016 Jun; 351(6):555-62. PubMed ID: 27238916
[TBL] [Abstract][Full Text] [Related]
11. The Utility of Soluble CD14 Subtype in Early Diagnosis of Culture-Proven Early-Onset Neonatal Sepsis and Prediction of Outcome.
Gad GI; Shinkar DM; Kamel El-Din MM; Nagi HM
Am J Perinatol; 2020 Apr; 37(5):497-502. PubMed ID: 30900217
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD14 subtype (sCD14-ST) as biomarker in neonatal early-onset sepsis and late-onset sepsis: a systematic review and meta-analysis.
van Maldeghem I; Nusman CM; Visser DH
BMC Immunol; 2019 Jun; 20(1):17. PubMed ID: 31159729
[TBL] [Abstract][Full Text] [Related]
13. Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients.
Matera G; Quirino A; Peronace C; Settembre P; Marano V; Loria MT; Marascio N; Galati L; Barreca GS; Giancotti A; Amantea B; Liberto MC; Focà A
Am J Med Sci; 2017 Jun; 353(6):543-551. PubMed ID: 28641717
[TBL] [Abstract][Full Text] [Related]
14. [Prediction value of plasma histone in prognosis of sepsis patients].
Lu N; Jiang L; Zhu B; Yang D; Zheng R; Shao J; Xi X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jun; 31(6):674-679. PubMed ID: 31315721
[TBL] [Abstract][Full Text] [Related]
15. Clinical Performance of a New Soluble CD14-Subtype Immunochromatographic Test for Whole Blood Compared with Chemiluminescent Enzyme Immunoassay: Use of Quantitative Soluble CD14-Subtype Immunochromatographic Tests for the Diagnosis of Sepsis.
Sato M; Takahashi G; Shibata S; Onodera M; Suzuki Y; Inoue Y; Endo S
PLoS One; 2015; 10(12):e0143971. PubMed ID: 26623644
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD14 subtype (sCD14-ST) is a biomarker for neonatal sepsis.
Chen L; Xiao T; Luo Y; Qiu Q; Que R; Huang X; Wu D
Int J Clin Exp Pathol; 2017; 10(9):9718-9724. PubMed ID: 31966854
[TBL] [Abstract][Full Text] [Related]
17. [Value of ATP synthase C subunit in predicting cardiac function and outcomes of sepsis].
Sun YY; Zhang YL; Zhang LY; Zhao GJ; Hong GL; Li MF; Wu B; Zhi SC; Lu ZQ
Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(27):2140-2146. PubMed ID: 34275249
[No Abstract] [Full Text] [Related]
18. [Impacts of sepsis-induced myocardial dysfunction on hemodynamics, organ function and prognosis in patients with septic shock].
Wang Z; Li H; Yao G; Zhu X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Mar; 27(3):180-4. PubMed ID: 25757966
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic risk factors of patients with sepsis and the clinical characteristics of patients with septic myocardial injury].
Mu W; Han Y; Gu G; Yao C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jul; 33(7):809-814. PubMed ID: 34412749
[TBL] [Abstract][Full Text] [Related]
20. [Risk factors and prognosis in critical patients with sepsis-related cardiomyopathy].
Zhang HM; Zhou GS; Zhang Q; Wang XT; Liu DW
Zhonghua Nei Ke Za Zhi; 2022 Jun; 61(6):644-651. PubMed ID: 35673744
[No Abstract] [Full Text] [Related]
[Next] [New Search]
